PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-58.58%
Negative net income growth while CRK stands at 108.58%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-11.88%
Both reduce yoy D&A, with CRK at -143.25%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-49.67%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
314.29%
SBC growth while CRK is negative at -12.56%. John Neff would see competitor possibly controlling share issuance more tightly.
-259.32%
Negative yoy working capital usage while CRK is 147.92%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-113.10%
Both yoy AR lines negative, with CRK at -192.28%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-259.32%
Negative yoy usage while CRK is 11023.85%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
163.89%
Well above CRK's 217.18%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-47.13%
Negative yoy CFO while CRK is 99.47%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
40.11%
Some CapEx rise while CRK is negative at -37.25%. John Neff would see competitor possibly building capacity while we hold back expansions.
-120.00%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-115.60%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
1691.67%
Liquidation growth of 1691.67% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
40.11%
Growth well above CRK's 38.13%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
20.47%
We have mild expansions while CRK is negative at -37.19%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-93.57%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.